(NASDAQ: ZLAB) Zai Lab's forecast annual revenue growth rate of 46.92% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.52%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.23%.
Zai Lab's revenue in 2024 is $266,719,000.On average, 4 Wall Street analysts forecast ZLAB's revenue for 2024 to be $378,745,249,801, with the lowest ZLAB revenue forecast at $373,421,708,652, and the highest ZLAB revenue forecast at $381,556,825,578. On average, 3 Wall Street analysts forecast ZLAB's revenue for 2025 to be $586,971,504,222, with the lowest ZLAB revenue forecast at $535,440,498,933, and the highest ZLAB revenue forecast at $630,471,561,765.
In 2026, ZLAB is forecast to generate $734,015,726,834 in revenue, with the lowest revenue forecast at $734,015,726,834 and the highest revenue forecast at $734,015,726,834.